To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Taken together, Merck, Eli Lilly ...
Pharmaceutical giant Merck, which maintains major operations in Montgomery County, has completed its $10 billion acquisition of Verona Pharma, writes the New Jersey Business and Industry Association.
President Donald Trump and Germany's Merck said they had struck a deal that would cut the cost of some drugs needed for in-vitro fertilization in exchange for protection from future tariffs. Ralf ...
Keytruda continues to dominate, driving 50% of revenue, with new approvals and delivery methods strengthening MRK's oncology leadership. The company’s long-term outlook is also promising, with a full ...
The 12th Edition of the Merck Foundation Africa Asia Luminary opened on October 14th 2025, at the Sir Dawda Kairaba Jawara International Conference Centre in Banjul, gathering over 6,000 delegates ...
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions JSR’s innovative Amsphere™ Protein A resin technology complements Merck’s ...
JSR Corp. (Tokyo) announced that it entered into an agreement to transfer its bioprocess materials business to Merck KGaA, Darmstadt, Germany, subject to closing conditions. The proposed transaction ...
Merck's two most important growth drivers are encountering headwinds now. While they are manageable, the company's mid-term prospects aren't strong. Merck's biggest growth drivers are cancer drug ...
Moderna has shared some of the phase 1/2 data that persuaded it to expand and prioritize development of a cancer candidate, reporting responses in melanoma patients failed by checkpoint inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback